Pharmaceutical strength antioxidant agents considered to treat AMD

MIAMI — A new generation of antioxidants under pharmaceutical development is intended for the treatment of age-related macular degeneration in manufactured doses greater than what can be obtained over the counter, a speaker said here. In models in which “megadoses” of vitamin E were used, drusen formation was hindered, but the doses would have been toxic in humans, Scott W. Cousins, MD, said at the Angiogenesis, Exudation, and Degeneration 2014 meeting. “It’s not that the antioxidant mechanism of action is wrong; it’s that the nutraceutical is not performing the way (Read more...)

Full Story →